Interesting TARS Put And Call Options For November 21st

The article analyzes options strategies for Tarsus Pharmaceuticals (TARS) stock, currently trading at $55.51, highlighting opportunities for yield enhancement and risk management. Selling a $50.00 strike put for a $1.40 premium offers a potential cost basis of $48.60 and a 16.21% annualized return if the option expires worthless (67% probability). Concurrently, a covered call strategy using a $60.00 strike call for a $0.50 premium could yield an 8.99% total return if the stock is called away, or a 5.22% annualized return if the call expires worthless (63% probability), with implied volatilities of 65% (put) and 53% (call) compared to TARS's 49% trailing 12-month actual volatility.

Analysis

The options market for Tarsus Pharmaceuticals (TARS), currently trading at $55.51, presents two distinct yield-enhancement strategies. For investors looking to initiate a position, selling the $50.00 strike put contract for a $1.40 premium provides an alternative entry point. This strategy establishes a cost basis of $48.60 if assigned, representing a 10% discount to the current market price. There is a 67% probability of this out-of-the-money put expiring worthless, which would generate a 16.21% annualized return on the cash commitment. For existing shareholders, a covered call strategy involving the $60.00 strike offers a potential 8.99% total return if the stock is called away by the November 21st expiration. The 63% probability of this call expiring worthless would result in a 5.22% annualized yield boost. Critically, the implied volatility is elevated in both the put (65%) and the call (53%) relative to the stock's trailing twelve-month actual volatility of 49%, suggesting that options premiums are currently rich compared to recent historical price action, a condition that generally favors option sellers.

Key Decisions for Investors

• Bullish investors not yet holding TARS could consider selling the $50.00 strike cash-secured put to either acquire shares at a discounted effective cost basis of $48.60 or capture a 16.21% annualized yield.
• Current TARS shareholders with a neutral to moderately bullish outlook might find the covered call strategy at the $60.00 strike attractive for generating income, but must be willing to cap their total return at 8.99% and sell their shares at $60.00.
• Given that implied volatility on TARS options is currently higher than its historical volatility, investors should recognize that selling options premium via either puts or calls is a potentially favorable strategy at present.